M. Caws et al., Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis, J CLIN MICR, 38(9), 2000, pp. 3150-3155
An open prospective clinical, microbiological, and molecular analysis of a
national molecular diagnostic service for tuberculous meningitis (TBM) usin
g an in-house IS6110-targeted PCR for molecular "Fastrack" diagnosis was ca
rried out. Between April 1997 and June 1998. Consecutive cerebrospinal flui
d (CSF) samples from 131 patients were assessed, Against a culture on the s
ame sample, PCR had a sensitivity of 75% and a specificity of 94%. Of sampl
es from patients classified as definite or probable TBM cases based on clin
ical criteria, 81% had raised CSF protein levels and 73% had a lymphocytosi
s, although 57% of all submitted samples showed a raised lymphocyte count.
While only 46% had a CSF glucose level below the normal range, the CSF gluc
ose level was significantly lower (P = 0.0281) than in cases of meningitis
of other etiologies, Levels of tumor necrosis factor alpha were also found
to be significantly raised in definite or probable TBM cases (P = 0.028), w
hile adenosine deaminase levels were not. The study showed IS6110-targeted
PCR to be a rapid, sensitive, and specific test in routine use for the diag
nosis of TBM.